Evaluation of cerebrospinal fluid glycoprotein NMB (GPNMB) as a potential biomarker for Alzheimer’s disease

BACKGROUND: Alzheimer’s disease (AD) is a neurodegenerative disorder associated with extracellular amyloid-β peptide deposition and progressive neuron loss. Strong evidence supports that neuroinflammatory changes such as the activation of astrocytes and microglia cells are important in the disease p...

Descripción completa

Detalles Bibliográficos
Autores principales: Aichholzer, Freyja, Klafki, Hans-Wolfgang, Ogorek, Isabella, Vogelgsang, Jonathan, Wiltfang, Jens, Scherbaum, Norbert, Weggen, Sascha, Wirths, Oliver
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097817/
https://www.ncbi.nlm.nih.gov/pubmed/33947460
http://dx.doi.org/10.1186/s13195-021-00828-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097817/
https://www.ncbi.nlm.nih.gov/pubmed/33947460
http://dx.doi.org/10.1186/s13195-021-00828-1

Ejemplares similares